GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Cash And Cash Equivalents

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Cash And Cash Equivalents : ¥1,097 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Cash And Cash Equivalents?

Zhejiang Garden Biopharmaceutical Co's quarterly cash and cash equivalents declined from Mar. 2024 (¥1,484.77 Mil) to Jun. 2024 (¥1,252.60 Mil) but then stayed the same from Jun. 2024 (¥1,252.60 Mil) to Sep. 2024 (¥1,097.14 Mil).

Zhejiang Garden Biopharmaceutical Co's annual cash and cash equivalents increased from Dec. 2021 (¥502.09 Mil) to Dec. 2022 (¥554.91 Mil) and increased from Dec. 2022 (¥554.91 Mil) to Dec. 2023 (¥1,502.87 Mil).


Zhejiang Garden Biopharmaceutical Co Cash And Cash Equivalents Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Cash And Cash Equivalents Chart

Zhejiang Garden Biopharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 505.74 1,160.89 502.09 554.91 1,502.87

Zhejiang Garden Biopharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,766.02 1,502.87 1,484.77 1,252.60 1,097.14

Zhejiang Garden Biopharmaceutical Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Zhejiang Garden Biopharmaceutical Co  (SZSE:300401) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Zhejiang Garden Biopharmaceutical Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Garden Biopharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director

Zhejiang Garden Biopharmaceutical Co Headlines

No Headlines